marcus evans north america conferences

2nd Annual Strategies in Patient Centered Clinical Research

Maximizing Existing Tools and Technology to Further Integrate the Patient Voice and Secure Investment for Patient Centered Clinical Research

18-19 Jul 2017
Boston, MA, United States of America

Why You Should Attend

2nd Annual Strategies in Patient Centered Clinical Research

Originally, the purpose of clinical research was to amass clinical data.  However, as a result of recent demands from patients and regulators alike pharmaceutical and biotech organizations are looking to utilize trials to obtain quality patient data to better align products to patient needs. By placing the emphasis on the patient, drug developers are able to pinpoint those outcomes most valued by patients and their caregivers and therefore advance products to address these needs.

By attending this Strategies in Patient Centered Clinical Research Conference, delegates will receive practical knowledge and tangible insights from leading clinical operations, innovation, and research professionals on how to overcome internal opposition to patient-centricity, collaborate with external groups to ensure robust patient populations, and assess motivational and behavioral factors for improved patient engagement and retention.

Key Topics

  • Collaborate with Senior Leadership to Define Success Criteria for Patient Centered Clinical Research with Astellas
  • Deconstruct the Recent Tufts University Study to Bolster Arguments for Increased Patient Centricity with Tufts University, Center for the Study of Drug Development
  • Measure the Impact of Patient Engagement to Power Patient Centric Clinical Research – A Quantitative Approach from the Clinical Trials Transformation Initiative with Horizon Pharma and CTTI
  • Evaluate the Role of Patients in Clinical Research to Improve the Patient Experience with Tesaro
  • Develop Partnerships with Advocacy Organizations to Heighten Awareness of Research Opportunities and Enhance Patient Engagement with Amgen, Shire, Ultragenyx, and Otsuka
  • Previous Attendees Include

    Amicus Therapeutics, Biogen, Bristol-Myers Squibb, Genzyme, Pfizer, Merck, Takeda Pharmaceuticals International, UCB

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Health Advocacy Strategies, LLC
    Visit website >>
    Center Point Clinical Services
    Visit website >>
    Visit website >>
    Visit website >>
    Symphony Clinical Research
    Visit website >>

    Event Partners

    Practical Insights From

    Jeffery W. Sherman, MD, FACP
    Chief medical Officer & Executive Vice President Research & Development
    Horizon Pharma

    Charmaine Gittleson
    Chief Medical Officer
    CSL Behring

    Rob Scott
    Chief Medical Officer, Vice President and Head of Development

    Anthony Yanni
    Head Medical Intelligence & Patient Perspectives

    Thomas J. Croce, Jr RPh
    Vice President, Global Advocacy Relations
    Amgen Inc.

    Julie Dietrich
    Director, Development Design Center
    Amgen Inc.

    Luther T. Clark, MD, FACC, FACP
    Global Director, Scientific Medical and Patient Perspective, Office of the Chief Patient Office

    Stella Stergiopoulos
    Senior Research Project Manager
    Tufts Center for the Study of Drug Development

    Click Here For Full Agenda

    Voice of Our Customers
    • "I continue to be impressed by the quality of speakers and depth of content at each marcus evans event" AstraZeneca
    • "Upto date, stimulating and interactive meeting. Enthusiastic audience and high quality speakers." Shire Pharmaceuticals
    • "Great focus." Gilead Sciences Inc.
    • "Well organized and complementary content & speakers." Duke Clinical Research Institute
    • "It was awesome to have multiple informative presentations and a presence by the FDA. Format was perfect with informative networking, small groups & panel discussion." Agios Pharmaceuticals
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    John Hummel

    NBC Tower, 9th Floor
    455 North Cityfront Plaza Drive
    Chicago, IL 60611

    312-540-3000 Ext: 6327
    Fax: 312.894.6304